All Stories
Follow
Subscribe to STRATEC Biomedical AG

STRATEC Biomedical AG

ots Ad hoc-Service: STRATEC Biomedical Sys. <DE0007289001> STRATEC Biomedical Systems AG Concludes Multi-Year Cooperation Contract with DADE BEHRING MARBURG GmbH

Birkenfeld (ots Ad hoc-Service) -

The sender is solely responsible for the contents of this
announcement.
STRATEC Biomedical Systems AG Birkenfeld (WKN 728900) is one of
the leading suppliers of automated systems for bioanalytical and
diagnostics applications.
STRATEC Biomedical Systems AG has concluded a cooperation
agreement with DADE BEHRING MARBURG GmbH for a period of several
years. Subject matter of this agreement is that STRATEC Biomedical
Systems AG shall supply DADE BEHRING with customized automated
analyzer systems for infectious disease diagnostics.
DADE BEHRING will market this system under the name 'BEP (r) 2000'
together with its 'Enzygnost(r)'-reagents. Product launch for this
new system will be early June 2000. Dade Behring expects to further
strenghten its position in the infectiious disease market and expand
into new market segments with this fully automated analyser.
With 1999 revenues of approximately $ 1.3 billion, Dade Behring is
among the largest clinical diagnostics companies in the world,
offering a wide range of products and systems for diagnostics
testing.
This major order will strengthen STRATEC's reputation in the field
of life sciences and diagnostics and its business outlook.
For further information, please contact: www.stratec-biomedical.de
ir@stratec-biomedical.de
or +49 (0) 7082 79 16 27

Original content of: STRATEC Biomedical AG, transmitted by news aktuell

More stories: STRATEC Biomedical AG
More stories: STRATEC Biomedical AG